Aptitude creates a special type of molecule called an aptamer, which it is using to develop a first-of-its-kind hand-held device that measures insulin concentrations in real-time and can diagnose pre-diabetes. The government’s interest in furthering such research is unsurprising as diabetes affects more than 9 percent of Americans.
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
